Garmin ECG App

FDA 510(k) K221774 · Garmin International, Inc.

Substantially Equivalent

510(k) numberK221774

Submission

Device name
Garmin ECG App
Applicant
Garmin International, Inc.
Olathe, KS, US
Received
June 21, 2022
Decision date
January 12, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QDA – Electrocardiograph Software For Over-The-Counter Use
Device class
Class II (moderate risk)
Regulation
21 CFR 870.2345
Specialty
Cardiovascular

An electrocardiograph software device for over-the-counter use creates, analyzes, and displays electrocardiograph data, and can provide information for identifying cardiac arrhythmias. This device is not intended to provide a diagnosis.

Other 510(k)s with product code QDA

510(k)DeviceApplicantDecision
K240795Withings ECG AppQDA · Traditional Withings06/15/2025SE
K243236WHOOP ECG (electrocardiogram) Feature (1.0)QDA · Traditional Whoop., Inc.04/04/2025SE
K240909Samsung ECG App v 1.3 (ECG)QDA · Traditional Samsung Electronics Co., Ltd.08/02/2024SE
K230292Samsung ECG Monitor Application with Irregular Heart Rhythm NotificationQDA · Traditional Samsung Electronics Co., Ltd.05/02/2023SE
K201525ECG AppQDA · Traditional Apple, Inc.10/08/2020SE
K200948Fitbit ECG AppQDA · Traditional Fitbit, Inc.09/11/2020SE
K201168ECG Monitor AppQDA · Traditional Samsung Electronics Co., Ltd.08/04/2020SE

Questions and answers

When was Garmin ECG App cleared by the FDA?

Garmin ECG App (K221774) received a 510(k) decision of Substantially Equivalent on January 12, 2023, 205 days after the submission was received.

What is the product code of K221774?

The FDA product code is QDA – Electrocardiograph Software For Over-The-Counter Use, a Class II (moderate risk) device regulated under 21 CFR 870.2345.